RBC Capital lowered CVS Health's target price to $58.
RBC Capital: lowered the target price for CVS Health from $68 to $58, maintaining an "outperform large cap" rating. (Gelonghui)
Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock -- Barrons.com
CVS Health (NYSE:CVS) Sheds US$3.0b, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
CVS Health's 2025 'Less Certain' Following 2024 Guidance Withdrawal, Changes in Leadership, RBC Capital Says
Analyst Expectations For CVS Health's Future
CVS Health Is Maintained at Outperform by RBC Capital